Furthermore, based on the topological parameters of nodes in the component-target network, it was speculated that PTGS2, PPARG, NOS2, and NR3C1 were the core targets for BFYSF in treating COPD. This evidence concerns the gene NR3C1 and chronic obstructive pulmonary disease.